In prostate cancer, overexpression of GCNT1 [β(1 → 6)-N-acetylglucosaminyltransferase, involved in core 2 O-glycan biosynthesis] was associated with higher levels of core 2 O-SLex in prostate specific antigen (PSA) (25). Here, KLK3 is linked to prostate carcinoma.